3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
15
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Hematologic Neoplasms
5
Neuroblastoma
4
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neoplasm, Residual
3
Leukemia, Myelomonocytic, Juvenile
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Interventions
Gemcitabine
8
Cisplatin
8
pembrolizumab
4
durvalumab
4
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
tivozanib
1
peposertib
1
guadecitabine
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
avelumab
1
atezolizumab
1
Trastuzumab
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Melphalan
×
90 days
×
Clear all
No trials found.